Peripheral Vascular Devices Market Size, Share, Trends, Growth Outlook

Peripheral Vascular Devices Market is estimated to increase at a Compounded Annual Growth Rate of 7.8% CAGR over the forecast period from 2024 to 2030

The Peripheral Vascular Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Angioplasty Balloons, Angioplasty Stents, Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Device Market, Others).

An Introduction to Peripheral Vascular Devices Market in 2024

Peripheral Vascular Devices encompass a wide range of medical devices used in the diagnosis and treatment of peripheral vascular diseases, including peripheral artery disease (PAD), deep vein thrombosis (DVT), and venous insufficiency. These devices include angioplasty balloons, stents, atherectomy devices, catheters, and venous compression stockings, among others. Peripheral vascular interventions aim to restore blood flow, alleviate symptoms, and prevent complications associated with vascular occlusions and abnormalities. Advancements in device design, materials, and delivery systems have improved procedural success rates, durability, and patient outcomes. Additionally, innovations in imaging modalities, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), enhance procedural planning and guidance, enabling precise placement of vascular devices. As the prevalence of peripheral vascular diseases continues to rise globally, peripheral vascular devices play a crucial role in improving limb salvage rates, reducing amputation rates, and enhancing quality of life for affected patients.

Market Trend: Minimally Invasive Peripheral Vascular Procedures

A significant trend in the peripheral vascular devices market is the increasing adoption of minimally invasive procedures for the treatment of peripheral vascular diseases. Minimally invasive techniques, such as angioplasty, stenting, atherectomy, and thrombectomy, offer less invasive alternatives to traditional open surgeries for treating peripheral artery disease (PAD), deep vein thrombosis (DVT), and other vascular conditions. These procedures involve smaller incisions, reduced recovery times, and fewer complications compared to conventional surgical interventions, driving their widespread acceptance among patients and healthcare providers. Additionally, advancements in peripheral vascular devices, such as drug-eluting stents, balloon catheters, and atherectomy devices, support the performance of minimally invasive procedures with improved efficacy, safety, and durability. This trend reflects a shift towards less invasive treatment modalities and a growing preference for endovascular approaches in peripheral vascular interventions.

Market Driver: Aging Population and Increasing Prevalence of Peripheral Vascular Diseases

A key driver for the peripheral vascular devices market is the aging population and the rising prevalence of peripheral vascular diseases. With an aging demographic worldwide, there is a higher incidence of vascular conditions such as PAD, DVT, and peripheral artery aneurysms, which contribute to significant morbidity and mortality. The growing prevalence of risk factors such as obesity, diabetes, and hypertension further exacerbates the burden of peripheral vascular diseases, driving the demand for diagnostic and therapeutic interventions. Peripheral vascular devices, including stents, balloons, catheters, and embolic protection devices, play a crucial role in the management of vascular diseases by restoring blood flow, preventing thrombosis, and reducing the risk of complications. As the prevalence of peripheral vascular diseases continues to rise, there is a growing need for innovative peripheral vascular devices that offer improved performance, durability, and patient outcomes.

Market Opportunity: Development of Advanced Drug-Eluting and Bioresorbable Devices

An emerging opportunity within the peripheral vascular devices market lies in the development of advanced drug-eluting and bioresorbable devices. Drug-eluting stents and balloons coated with anti-proliferative or anti-restenotic drugs have revolutionized the treatment of peripheral artery disease by reducing rates of restenosis and revascularization compared to bare-metal devices. Similarly, bioresorbable scaffolds and implants offer the potential for temporary vessel support and drug delivery while gradually resorbing into the body, eliminating the long-term risks associated with permanent implants. By investing in research and development efforts, manufacturers can innovate in the design, materials, and drug delivery mechanisms of peripheral vascular devices to enhance their efficacy, biocompatibility, and long-term safety profiles. This presents an opportunity to develop next-generation peripheral vascular devices that offer personalized treatment options, minimize adverse events, and improve patient outcomes in peripheral vascular interventions.

Peripheral Vascular Devices Market Share Analysis: Angioplasty Balloons is the fastest growing segment over the forecast period to 2030

The fastest-growing segment in the Peripheral Vascular Devices Market is Angioplasty Balloons, specifically Drug-Eluting Angioplasty Balloons within the Product category. This growth is driven by advancements in angioplasty techniques and the increasing adoption of drug-eluting balloons for the treatment of peripheral artery disease (PAD) and other vascular conditions. Drug-eluting angioplasty balloons deliver anti-proliferative drugs directly to the vessel wall during balloon inflation, reducing restenosis rates and improving long-term outcomes compared to traditional angioplasty balloons. Additionally, the development of cutting and scoring balloons further enhances the efficacy of angioplasty procedures, contributing to the rapid growth of Drug-Eluting Angioplasty Balloons in the Peripheral Vascular Devices Market.

Peripheral Vascular Devices Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, AMG International GmbH, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group Ltd, Biotronik SE & Co. KG, Boston Scientific Corp, Cordis Corp, Endocor GmbH, iVascular, S.L.U., Koninklijke Philips N.V., Medtronic plc, Merit Medical Systems Inc, Penumbra Inc, Terumo Corp

Peripheral Vascular Devices Market Segmentation

By Product
Angioplasty Balloons
-Old/Normal
-Cutting and Scoring
-Drug-Eluting
Angioplasty Stents
-Drug-eluting
-Bare metal
-Self-expandable
-Balloon-expandable
Catheters
-Angiography
-IVUS/OCT
-Guiding
Endovascular Aneurysm Repair Stent Grafts
-Abdominal Aortic Aneurysm Stent Grafts
-Thoracic Aortic Aneurysm Stent Grafts
Inferior Vena Cava Filters
-Retrievable
-Permanent
Plaque Modification Devices
-Atherectomy
-Thrombectomy
Hemodynamic Flow Alteration Device Market
-Embolic Protection Devices
-Chronic Total Occlusion Devices
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Peripheral Vascular Devices Market Companies

Abbott Laboratories
AMG International GmbH
B. Braun Melsungen AG
Becton, Dickinson and Company
Biosensors International Group Ltd
Biotronik SE & Co. KG
Boston Scientific Corp
Cordis Corp
Endocor GmbH
iVascular, S.L.U.
Koninklijke Philips N.V.
Medtronic plc
Merit Medical Systems Inc
Penumbra Inc
Terumo Corp

Reasons to Buy the Peripheral Vascular Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Peripheral Vascular Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Peripheral Vascular Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Peripheral Vascular Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Peripheral Vascular Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Peripheral Vascular Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Peripheral Vascular Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Peripheral Vascular Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Peripheral Vascular Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Peripheral Vascular Devices Industry
4.2 Key Market Trends in Peripheral Vascular Devices Industry
4.3 Potential Opportunities in Peripheral Vascular Devices Industry
4.4 Key Challenges in Peripheral Vascular Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Peripheral Vascular Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Peripheral Vascular Devices Market Outlook by Segments
7.1 Peripheral Vascular Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Angioplasty Balloons
-Old/Normal
-Cutting and Scoring
-Drug-Eluting
Angioplasty Stents
-Drug-eluting
-Bare metal
-Self-expandable
-Balloon-expandable
Catheters
-Angiography
-IVUS/OCT
-Guiding
Endovascular Aneurysm Repair Stent Grafts
-Abdominal Aortic Aneurysm Stent Grafts
-Thoracic Aortic Aneurysm Stent Grafts
Inferior Vena Cava Filters
-Retrievable
-Permanent
Plaque Modification Devices
-Atherectomy
-Thrombectomy
Hemodynamic Flow Alteration Device Market
-Embolic Protection Devices
-Chronic Total Occlusion Devices
Others

8 North America Peripheral Vascular Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Peripheral Vascular Devices Markets in 2024
8.2 North America Peripheral Vascular Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Peripheral Vascular Devices Market size Outlook by Segments, 2021-2030
By Product
Angioplasty Balloons
-Old/Normal
-Cutting and Scoring
-Drug-Eluting
Angioplasty Stents
-Drug-eluting
-Bare metal
-Self-expandable
-Balloon-expandable
Catheters
-Angiography
-IVUS/OCT
-Guiding
Endovascular Aneurysm Repair Stent Grafts
-Abdominal Aortic Aneurysm Stent Grafts
-Thoracic Aortic Aneurysm Stent Grafts
Inferior Vena Cava Filters
-Retrievable
-Permanent
Plaque Modification Devices
-Atherectomy
-Thrombectomy
Hemodynamic Flow Alteration Device Market
-Embolic Protection Devices
-Chronic Total Occlusion Devices
Others

9 Europe Peripheral Vascular Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Peripheral Vascular Devices Markets in 2024
9.2 Europe Peripheral Vascular Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Peripheral Vascular Devices Market Size Outlook by Segments, 2021-2030
By Product
Angioplasty Balloons
-Old/Normal
-Cutting and Scoring
-Drug-Eluting
Angioplasty Stents
-Drug-eluting
-Bare metal
-Self-expandable
-Balloon-expandable
Catheters
-Angiography
-IVUS/OCT
-Guiding
Endovascular Aneurysm Repair Stent Grafts
-Abdominal Aortic Aneurysm Stent Grafts
-Thoracic Aortic Aneurysm Stent Grafts
Inferior Vena Cava Filters
-Retrievable
-Permanent
Plaque Modification Devices
-Atherectomy
-Thrombectomy
Hemodynamic Flow Alteration Device Market
-Embolic Protection Devices
-Chronic Total Occlusion Devices
Others

10 Asia Pacific Peripheral Vascular Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Peripheral Vascular Devices Markets in 2024
10.2 Asia Pacific Peripheral Vascular Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Peripheral Vascular Devices Market size Outlook by Segments, 2021-2030
By Product
Angioplasty Balloons
-Old/Normal
-Cutting and Scoring
-Drug-Eluting
Angioplasty Stents
-Drug-eluting
-Bare metal
-Self-expandable
-Balloon-expandable
Catheters
-Angiography
-IVUS/OCT
-Guiding
Endovascular Aneurysm Repair Stent Grafts
-Abdominal Aortic Aneurysm Stent Grafts
-Thoracic Aortic Aneurysm Stent Grafts
Inferior Vena Cava Filters
-Retrievable
-Permanent
Plaque Modification Devices
-Atherectomy
-Thrombectomy
Hemodynamic Flow Alteration Device Market
-Embolic Protection Devices
-Chronic Total Occlusion Devices
Others

11 South America Peripheral Vascular Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Peripheral Vascular Devices Markets in 2024
11.2 South America Peripheral Vascular Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Peripheral Vascular Devices Market size Outlook by Segments, 2021-2030
By Product
Angioplasty Balloons
-Old/Normal
-Cutting and Scoring
-Drug-Eluting
Angioplasty Stents
-Drug-eluting
-Bare metal
-Self-expandable
-Balloon-expandable
Catheters
-Angiography
-IVUS/OCT
-Guiding
Endovascular Aneurysm Repair Stent Grafts
-Abdominal Aortic Aneurysm Stent Grafts
-Thoracic Aortic Aneurysm Stent Grafts
Inferior Vena Cava Filters
-Retrievable
-Permanent
Plaque Modification Devices
-Atherectomy
-Thrombectomy
Hemodynamic Flow Alteration Device Market
-Embolic Protection Devices
-Chronic Total Occlusion Devices
Others
12 Middle East and Africa Peripheral Vascular Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Peripheral Vascular Devices Markets in 2024
12.2 Middle East and Africa Peripheral Vascular Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Peripheral Vascular Devices Market size Outlook by Segments, 2021-2030
By Product
Angioplasty Balloons
-Old/Normal
-Cutting and Scoring
-Drug-Eluting
Angioplasty Stents
-Drug-eluting
-Bare metal
-Self-expandable
-Balloon-expandable
Catheters
-Angiography
-IVUS/OCT
-Guiding
Endovascular Aneurysm Repair Stent Grafts
-Abdominal Aortic Aneurysm Stent Grafts
-Thoracic Aortic Aneurysm Stent Grafts
Inferior Vena Cava Filters
-Retrievable
-Permanent
Plaque Modification Devices
-Atherectomy
-Thrombectomy
Hemodynamic Flow Alteration Device Market
-Embolic Protection Devices
-Chronic Total Occlusion Devices
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
AMG International GmbH
B. Braun Melsungen AG
Becton, Dickinson and Company
Biosensors International Group Ltd
Biotronik SE & Co. KG
Boston Scientific Corp
Cordis Corp
Endocor GmbH
iVascular, S.L.U.
Koninklijke Philips N.V.
Medtronic plc
Merit Medical Systems Inc
Penumbra Inc
Terumo Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Angioplasty Balloons
-Old/Normal
-Cutting and Scoring
-Drug-Eluting
Angioplasty Stents
-Drug-eluting
-Bare metal
-Self-expandable
-Balloon-expandable
Catheters
-Angiography
-IVUS/OCT
-Guiding
Endovascular Aneurysm Repair Stent Grafts
-Abdominal Aortic Aneurysm Stent Grafts
-Thoracic Aortic Aneurysm Stent Grafts
Inferior Vena Cava Filters
-Retrievable
-Permanent
Plaque Modification Devices
-Atherectomy
-Thrombectomy
Hemodynamic Flow Alteration Device Market
-Embolic Protection Devices
-Chronic Total Occlusion Devices
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)